Skip to main content
Premium Trial:

Request an Annual Quote

Chembio Diagnostics: Gail Page

Chembio Diagnostics has appointed Gail Page, a company director, as its interim CEO and has initiated an executive search to identify a permanent CEO. John Sperzel has resigned as Chembio's president and CEO and replaced John McDonough as T2 Biosystems' president and CEO.

Page has served on Chembio's board of directors since 2017. She is a venture partner at Turret Capital Management and was previously president and CEO at Vermillion. Further, she served as chief operating officer of Luminex for three years and Roche Biomedical Laboratories, which is now Laboratory Corporation of America, for 12 years.